• Epidemiology and risk quantification across decades show dose-response links between tobacco exposure and lung cancer, cardiovascular disease, and mortality, derived from large prospective follow-ups and cohort analyses [4], [7], [9], [10], [14], [19].

• Biological mechanism research blends tar carcinogenesis experiments, cocarcinogenic activity of cigarette tobacco tar, and systemic biologic effects to connect tobacco constituents with tumor initiation and cardiovascular perturbations [13], [15], [18], [20].

• Behavioral science and social-determinant perspectives map smoking uptake, habit formation, gender/age differences, emotional correlates, and wide prevalence among youths and adults, highlighting individual and contextual factors in tobacco use [1], [3], [8], [11], [12], [16].

• Public health policy-oriented analyses synthesize health outcomes, policy implications, and regulatory considerations, framing tobacco control as a public health problem supported by population-level data and policy-relevant risk assessments [1], [2], [5], [19].

• Methodological development spans physiological testing, epidemiological design, and comparative studies, advancing tools to assess smoking effects and behavioral patterns across populations [3], [6], [8], [11], [16].